Subscribe to Newsletter

Search

Reset Filter

8 search results for ‘gen li’

Discovery & Development Clinical Trials

Why Reducing Complexity Can Lead to Better Clinical Trials

| 6 min read

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.


Discovery & Development Clinical Trials

Clinical Arms

| 4 min read

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

Discovery & Development Clinical Trials

Clinical Trials and Digital Doubles

| 5 min read

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Discovery & Development Clinical Trials

The World’s Most Studied Disease

| Rob Coker | 5 min read

Breast cancer was the most researched disease in 2022. Phesi CEO Gen Li discusses what helps and what hinders the breast cancer research process.

Discovery & Development Clinical Trials

Giving Data the Gift of Meaning

| Gen Li, Jonathan Peachey

Clinical trials need an overhaul – and AI is the solution.

Discovery & Development Clinical Trials

Data Damage

| Angus Stewart

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Business & Regulation Profession

Pharma and Fordism

| Angus Stewart | 10 min read

Sitting Down With… Gen Li, CEO, Phesi

1222

December 2022 Issue of The Medicine Maker

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register